Why the study?
The study was conducted to determine operational requirements and validate governance, data quality, and data security for assembling an international dataset, and to describe characteristics and outcomes of STEMI patients undergoing PCI in the Asia-Pacific region.
Harmonising individual patient-level registry data across the Asia-Pacific region is feasible and highlights significant regional variations in patient characteristics and in-hospital STEMI outcomes.
Answers are grounded in this paper and cite their sources.
Regional STEMI registry harmonization is feasible across Asia-Pacific; leaves open drivers of mortality variation for prospective investigation.
OBJECTIVE: The Asia-Pacific Evaluation of Cardiovascular Therapies (ASPECT) collaboration was established to inform on percutaneous coronary intervention (PCI) in the Asia-Pacific Region. Our aims were to (i) determine the operational requirements to assemble an international individual patient dataset and validate the processes of governance, data quality and data security, and subsequently (ii) describe the characteristics and outcomes for ST-elevation myocardial infarction (STEMI) patients undergoing PCI in the ASPECT registry. METHODS: Seven (7) ASPECT members were approached to provide a harmonised anonymised dataset from their local registry. Patient characteristics were summarised and associations between the characteristics and in-hospital outcomes for STEMI patients were analysed. RESULTS: Six (6) participating sites (86%) provided governance approvals for the collation of individual anonymised patient data from 2015 to 2017. Five (5) sites (83%) provided >90% of agreed data elements and 68% of the collated elements had <10% missingness. From the registry (n=12,620), 84% were male. The mean age was 59.2±12.3 years. The Malaysian cohort had a high prevalence of previous myocardial infarction (34%), almost twice that of any other sites (p<0.001). Adverse in-hospital outcomes were the lowest in Hong Kong whilst in-hospital mortality varied from 2.7% in Vietnam to 7.9% in Singapore. CONCLUSIONS: Governance approvals for the collation of individual patient anonymised data was achieved with a high level of data alignment. Secure data transfer process and repository were established. Patient characteristics and presentation varied significantly across the Asia-Pacific region with this likely to be a major predictor of variations in the clinical outcomes observed across the region.
No takes yet. Share an insight, caveat, or question.
Reid et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: